Type 2 diabetes in Brazil: Epidemiology and management

Diabetes, Metabolic Syndrome and Obesity

Volumn 8, Issue , 2015, Pages 17-28

  de Almeida Pititto, Bianca ^a   Dias, Monike Lourenço ^b   de Moraes, Ana Carolina Franco ^c   Ferreira, Sandra R G ^c   Franco, Denise Reis ^d   Eliaschewitz, Freddy Goldberg ^d,e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CPCLIN Clinical Research Center   (Brazil)

^e HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Brazil; Epidemiology; Management; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN; SULFONYLUREA;

AGE DISTRIBUTION; BLOOD GLUCOSE MONITORING; BRAZIL; CARDIOVASCULAR MORTALITY; COMORBIDITY; DIABETES EDUCATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIAGNOSTIC TEST; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH; RETINOPATHY; REVIEW; RISK FACTOR; SEX RATIO; SMOKING; VASCULAR DISEASE;

EID: 84942808776     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S72542     Document Type: Review

References (68)

1. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasieira de Diabetes: 2013–2014. Barueri, Brazil: AC Farmacêutica Ltda.; 2014. Available from: http://www.nutritotal.com.br/diretrizes/files/342--diretrizessbd.pdf. Accessed December 12, 2014. Portuguese.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053.
3. World Health Organization. Diabetes Fact Sheet. 2013. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed October 19, 2014.
4. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
5. National Diabetes Information Clearinghouse. Causes of diabetes. 2014. Available from: http://diabetes.niddk.nih.gov/dm/pubs/causes/. Accessed October 19, 2014.
6. Bertoldi AD, Kanavos P, Franca GV, et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health. 2013;9:62.
7. American Diabetes Association. Standards in medical care in diabetes – 2014. Diabetes Care. 2014;37 Suppl 1:S14–S80.
8. Batista Filho M, Rissin A. [Nutritional transition in Brazil: geographic and temporal trends]. Cad Saude Publica. 2003;19 Suppl 1:S181–S191. Portuguese.
9. Sartorelli DS, Franco LJ. [Trends in diabetes mellitus in Brazil: the role of the nutritional transition]. Cad Saude Publica. 2003;19 Suppl 1:S29–S36. Portuguese.
10. Schmidt MI, Duncan BB, Azevedo e Silva G, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011;377(9781):1949–1961.
11. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30–69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992;15(11):1509–1516.
12. Bosi PL, Carvalho AM, Contrera D, et al. Prevalence of diabetes and impaired glucose tolerance in the urban population of 30 to 79 years of the city of Sao Carlos, Sao Paulo. Arq Bras Endocrinol Metabol. 2009;53(6):726–732.
13. Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância de Doenças e Agravos não transmissíveis e Promoção da Saúde. VIGITEL Brasil 2013: Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília (DF): Ministério da Saúde; 2014. Available from: http://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/arquivos/morbidade/Vigitel-2013.pdf. Accessed december 12, 2014. Portuguese.
14. Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Análise de Situação de Saúde. [Strategic Action Plan to Tackle Noncommunicable Diseases (NCD) in Brazil, 2011–2022]. Brasília (DF): Ministério da Saúde; 2011. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/plano_acoes_enfrent_dcnt_2011.pdf. Accessed December 12, 2014. Portuguese.
15. Gimeno SGA, Ferreira SRG, Franco LJ, Harima H, Moisés RCS; Japanese-Brazilian Diabetes Study Group. Cardiovascular mortality in Japanese-Brazilians according to category of glucose tolerance. Diabetes. 2002;51 Suppl 2:A225.
16. Andrade RCG, Figueiredo RC, Foss-Freitas MC, et al. Prevalence of diabetes mellitus in the Japanese-Brazilian community of Mombuca, Guatapará, SP. Arq Bras Endocrinol Metabol. 2011;55(2):127–133.
17. Vieira Filho JPB. [O diabetes mellitus e as glicemias de jejum dos índios Caripuna e Palikur]. Revista da Associação Médica Brasileira. 1977;23:175–178. Portuguese.
18. Bloch KV, Coutinho ESF, Lobo MEC, Oliveira JEP, Milech A. [Pressão arterial, glicemia capitar e medidas antropométricas em uma população Yanomámi]. Cad Saúde Pública. 1993;9:428–438. Portuguese.
19. Dal Fabbro AL, Franco LJ, Silva AS, et al. High prevalence of type 2 diabetes mellitus in Xavante indians from Mato Grosso, Brazil. Ethn Dis. 2014;24:35–40.
20. Cabrera MAS, Jacob Filho W. [Obesidade em Idosos: Prevalência, Distribuição e Associação Com Hábitos e Co-Morbidades]. Arq Bras Endocrinol Metabol. 2001;45(5):494–501. Portuguese.
21. Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27(3):788–793.
22. Rtveladze K, Marsh T, Webber L, et al. Health and economic burden of obesity in Brazil. PLoS One. 2013;8(7):e68785.
23. Instituto Brasileiro de Geografia e Estatística IBGE. Pesquisa de Orçamentos Familiares 2008–2009: Análise da disponibilidade domiciliar de alimentos e do estado nutricional no Brasil. Rio de Janeiro: IBGE; 2010. Available from: http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009_aval_nutricional/pof20082009_avaliacao.pdf. Accessed October 20, 2014.
24. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004;27(2):538–546.
25. van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in US men. Ann Intern Med. 2002;136(3):201–209.
26. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004;23(4):447–456.
27. Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2011;21 Suppl 2:B32–B48.
28. Wannamethee SG, Whincup PH, Thomas MC, Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care. 2009;32(10):1823–1825.
29. Pimentel GD, Portero-McLellan KC, Oliveira EP, et al. Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance. Nutr Res. 2010;30(3):186–190.
30. Esposito K, Ceriello A, Giugliano D. Diet and the metabolic syndrome. Metab Syndr Relat Disord. 2007;5(4):291–296.
31. Hu FB, Sigal RJ, Rich-Edwards JW, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999;282(15):1433–1439.
32. Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care. 2007;30(3):744–752.
33. Santos ALT, Weiss T, Duarte CK, Azevedo MJ, Zelmanovitz T. [Análise crítica das recomendações da Associação Americana de Diabetes para doença cardiovascular no diabetes melito]. Arq Bras Endocrinol Metabol. 2009;53(5):657–666. Portuguese.
34. Gadelha AMJ, Leite IC, Valente JG, Schramm JMA, Portela MC, Campos MR. Relatório Final do Projeto Estimativa da Carga de Doença do Brasil – 1998. Rio de Janeiro: ENSP/Fiocruz-FENSPTEC; 2002.
35. Bahia LR, Araujo DV, Schaan BD, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011;14(5 Suppl 1):S137–S140.
36. [No authors listed] Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36(4):1033–1046.
37. Jonsson B. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45(7):S5–S12.
38. Rosa RS, et al. [Internações por Diabetes Mellitus como diagnóstico principal na Rede Pública do Brasil]. Rev Bras Epidemiol. 9007;10(4): 465–478. Portuguese.
39. Gerstein HC, Pogue J, Mann JF, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. 2005;48(9):1749–1755.
40. Calsbeek H, Ketelaar NA, Faber MJ, Wensing M, Braspenning J. Performance measurements in diabetes care: the complex task of selecting quality indicators. Int J Qual Health Care. 2013;25(6):704–709.
41. Ahmann AJ. Guidelines and performance measures for diabetes. Am J Manag Care. 2007;13 Suppl 2:S41–S46.
42. Viana LV, Leitao CB, Kramer CK, et al. Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open. 2013;3(9):e003336.
43. Lopez Stewart G, Tambascia M, Rosas Guzman J, Etchegoyen F, Ortega Carrion J, Artemenko S. [Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America]. Rev Panam Salud Publica. 2007;22(1):12–20. Spanish.
44. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013. Endocr Pract. 2013;19 Suppl 1:1–48.
45. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2012–2013. Available from: http://www.diabetes.org.br/para-profissionais/diretrizes-da-sbd. Accessed October 20, 2014.
46. Escalante M, Gagliardino JJ, Guzman JR, Tschiedel B. Call-to-action: timely and appropriate treatment for people with type 2 diabetes in Latin America. Diabetes Res Clin Pract. 2014;104(3):343–352.
47. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Estratégias para o cuidado da pessoa com doença crônica: diabetes mellitus. Cadernos de Atenção Básica, n 36. Brasília; 2013.
48. Torres HC, Rozemberg B, Amaral MA, Bodstein RC. Perceptions of primary healthcare professionals towards their role in type 2 diabetes mellitus patient education in Brazil. BMC Public Health. 2010;10:583.
49. Scain SF, Friedman R, Gross JL. A structured educational program improves metabolic control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Educ. 2009;35(4):603–611.
50. Robles C, Mirosevic V. Social protection systems in Latin America and the Caribbean: Brazil. Economic Commission for Latin America, September 2013. Available from: http://www.cepal.org/publicaciones/xml/7/51397/SPS_Brasil_esp.pdf. Accessed July 8, 2014.
51. Pinto Cdu B, Miranda ES, Emmerick IC, Costa Ndo R, Castro CG. Medicine prices and availability in the Brazilian Popular Pharmacy Program. Rev Saude Publica. 2010;44(4):611–619.
52. Brasil. Ministério da Saúde. SISHIPERDIA [Internet]. DATASUS Departamento de Informática do SUS. 2011. Available from: http://hiperdia.datasus.gov.br/. Acessed July 8, 2014.
53. Correia LO, Padilha BM, Vasconcelos SM. [Accuracy of registration data for patients with arterial hypertension and diabetes mellitus recorded in the Hiperdia system in a state in the northeast of Brazil]. Ciencia and Saude Coletiva. 2014;19(6):1685–1697. Portuguese.
54. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350.
55. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
56. Almeida-Pititto B, Griffin SJ, Sharp SJ, Hirai AT, Gimeno SG, Ferreira SR. A behavioral intervention in a cohort of Japanese-Brazilians at high cardiometabolic risk. Rev Saude Publica. 2012;46(4):602–609.
57. Barros CR, Cezaretto A, Salvador EP, Santos TC, Siqueira-Catania A, Ferreira SRG. [Um programa estruturado, factível e promissor de hábitos de vida saudáveis para redução de risco cardiometabólico]. Arq Brás Endocrinol Metabol. 2013;57(1):7–18. Portuguese.
58. Sartorelli DS, Sciarra EC, Franco LJ, Cardoso MA. Primary prevention of type 2 diabetes through nutritional counseling. Diabetes Care. 2004;27(12):3019.
59. [No authors listed]. Diabetes Control and Complications Trial: results of feasibility study. The DCCT Research Group. Diabetes Care. 1987;10(1):1–19.
60. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–648.
61. Pedersen O, Gaede P. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study. Metabolism. 2003;52(8 Suppl 1):19–23.
62. Margolis KL, O’Connor PJ, Morgan TM, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care. 2014;37(6):1721–1728.
63. Hirakawa Y, Arima H, Zoungas S, et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care. 2014;37(8):2359–2365.
64. Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, Reaven P. Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetologia. 2014;57(6):1124–1131.
65. Campos FE, Haddad AE, Chao LW, Alkmim MBM, Cury PM. The National Telehealth Program in Brazil: an instrument of support for primary health care. Latin American Journal of Telehealth. 2009;1(1): 39–59.
66. Chao LW. [Telemedicina e Telessaúde – Um panorama no Brasil. IP (Informática Pública)]. Prefeitura de Belo Horizonte. 2008;10(2): 7–15.
67. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23(10):1563–1580.
68. SIHD [homepage on the Internet]. Brazil: SUS Hospital Information System, Ministry of Health; 2014. Available from: http://www2.datasus.gov.br/SIHD. Accessed December 12, 2014.